Studying the effect of brown sugar consumption on the levels of pro-inflammatory cytokines, hemoglobin A1C, and fasting blood sugar in patients with type 2 diabetes referred to Ganjwaian Hospital in Dezful

Studying the effect of brown sugar consumption on the levels of pro-inflammatory cytokines, hemoglobin A1C, and fasting blood sugar in patients with type 2 diabetes referred to Ganjwaian Hospital in Dezful (a double-blind clinical trial)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250206064668N1

Enrollment

Registered

2025-03-06

Start date

2025-03-05

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Receiving brown sugar (replacing the allowed quota of white sugar in the diet under the supervision of an endocrinologist and nutrition expert) 15 grams per day for

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 30–70 years of age, with T2DM [fasting blood glucose (FBG) = 126 mg/dL, measured twice, 2-h plasma glucose = 200 mg/dL, or HbA1C = 6.5% or taking oral hypoglycemic medications], having a history of diabetes between 1 and 10 years, and having a body mass index (BMI) of 25–35 kg/m2.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HbA1c, IL-6t TNF-a. Timepoint: Once before treatment and 3 month after. Method of measurement: ELISA.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbdolkarim Sheikhi

Dezfoul University of Medical Sciences

sheikhi@queensu.ca+98 61 4242 9733

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026